AIFF - MCAP CO - Firefly Neuroscience, Inc

The Firefly Neuroscience, Inc (AIFF) price chart, recorded at 0.03, is based on the use of external cloud systems for data storage and EEG processing during autonomous software development. The robotization of diagnostics via neural networks automates the detection of pathologies, although the final diagnosis is made by a physician. The company is currently entering the monetization stage, engaging psychiatric centers to implement objective dementia tests.

Market capitalization is the product of the current share price and the total number of outstanding shares, reacting instantaneously to shifts in market expectations. This indicator determines the aggregate value of the business, serving as a fundamental measure of its economic weight. For Firefly Neuroscience, Inc (AIFF), the valuation reflects the scaling potential of its AI platform following FDA approval. However, modest clinical adoption is temporarily limiting value growth. The company's market capitalization dynamics clearly demonstrate this transition from a pre-scale plateau to commercial realization.